Verve Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Verve Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Verve Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Verve Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.0M | 215k | 4.84 |
| 2024-06-30 | $1.3M | 275k | 4.88 |
| 2024-03-31 | $3.0M | 225k | 13.28 |
| 2023-12-31 | $2.8M | 200k | 13.94 |
| 2023-09-30 | $2.5M | 187k | 13.26 |
| 2023-06-30 | $3.5M | 187k | 18.75 |
| 2023-03-31 | $2.5M | 171k | 14.42 |
| 2022-12-31 | $3.4M | 174k | 19.35 |
| 2022-09-30 | $11M | 170k | 66.67 |
| 2022-06-30 | $1.6M | 104k | 15.30 |
| 2022-03-31 | $2.6M | 116k | 22.82 |
| 2021-12-31 | $2.9M | 79k | 36.88 |
| 2021-09-30 | $2.6M | 56k | 47.01 |